A recent study found that around 14,000 patients with cancer could have reduced risk of harmful side effects from cancer ...

A new study led by Genomics England and Queen Mary University of London estimates that genetic testing could identify approximately 14,540 patients per year on any of 5 commonly prescribed drugs who ...

In this explainer episode, we’ve asked Callum Morris, Pharmaceutical Research and Development Insights Manager at Genomics England, to explain what happens in a clinical trial. You can also find a ...

In this explainer episode, we’ve asked Nicole Chai, Research and Development Bioinformatician at Genomics England, to explain what X-linked inheritance is. You can also find a series of short videos ...

All analysis on the Genomics England dataset happens within a secure, cloud workspace called the Research Environment. To access the data, researchers must first apply to become a member of either the ...

We have developed a machine learning tool for scanning large volumes of scientific literature to find reports of gene-disease associations using AWS Cloud services and Large Language Models. This will ...

In this explainer episode, we’ve asked Arina Puzriakova, Scientific Curator at Genomics England, to explain what a polygenic disorder is. You can also find a series of short videos explaining some of ...

The Participant Panel is made up of a diverse group of people whose data is held in the National Genomic Research Library. Members come from different walks of life and bring their life experiences of ...

Genomic medicine is already helping more people receive answers about their health conditions through better diagnosis, treatment, and support. By volunteering to take part in research, you'll be ...

The Generation Study is a research initiative aiming to explore the use of whole genome sequencing in newborns, to screen for more than 200 rare genetic conditions. This study will recruit 100,000 ...

Genomics England is part of a nationwide team of universities, hospitals and industry led by the Francis Crick Institute and The Royal Marsden NHS Foundation Trust, which has launched a new platform ...